Year All2024202320222021202020192018201720162015 Poseida Therapeutics to Join Russell 3000® and Russell 2000® Indexes June 26, 2023 Poseida Therapeutics Announces Virtual 2023 Annual Meeting of Stockholders June 1, 2023 Poseida Therapeutics to Present at Stifel 2023 Tailoring Genes: Genetic Medicines Day May 23, 2023 Poseida Therapeutics to Present at 31st Congress of the International Society on Thrombosis and Haemostasis May 22, 2023 Poseida Therapeutics Presents Encouraging Preclinical Data Across its Gene Therapy Programs at the American Society for Gene and Cell Therapy 2023 Annual Meeting May 18, 2023 Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2023 May 9, 2023 Poseida Therapeutics Announces Multiple Presentations at the American Society of Gene and Cell Therapy 26th Annual Meeting May 2, 2023 Poseida Therapeutics to Present at BofA Securities 2023 Health Care Conference May 1, 2023 Poseida Therapeutics Appoints Rafael G. Amado, M.D., to Board of Directors April 13, 2023 Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) April 11, 2023
Poseida Therapeutics to Present at 31st Congress of the International Society on Thrombosis and Haemostasis May 22, 2023
Poseida Therapeutics Presents Encouraging Preclinical Data Across its Gene Therapy Programs at the American Society for Gene and Cell Therapy 2023 Annual Meeting May 18, 2023
Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2023 May 9, 2023
Poseida Therapeutics Announces Multiple Presentations at the American Society of Gene and Cell Therapy 26th Annual Meeting May 2, 2023
